![]() |
Volumn 37, Issue 3, 2005, Pages 1519-1522
|
Pediatric lung transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIVIRUS AGENT;
AZATHIOPRINE;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
ADOLESCENT;
ANTIBIOTIC SENSITIVITY;
ARTERIAL OXYGEN TENSION;
ARTIFICIAL VENTILATION;
CHILD;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
DEMOGRAPHY;
DIABETIC NEUROPATHY;
FEMALE;
FORCED EXPIRATORY VOLUME;
FUNGUS;
GAS EXCHANGE;
GRAFT REJECTION;
HIRSUTISM;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTENSIVE CARE UNIT;
KARTAGENER SYNDROME;
LUNG FIBROSIS;
LUNG FUNCTION;
LUNG TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MYCOSIS;
PEDIATRICS;
PNEUMONIA;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SIDE EFFECT;
SURVIVAL;
VIRUS INFECTION;
ADOLESCENT;
ADULT;
CARBON DIOXIDE;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INTRAOPERATIVE CARE;
LUNG TRANSPLANTATION;
MALE;
OXYGEN;
PARTIAL PRESSURE;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
|
EID: 19044362073
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.02.005 Document Type: Conference Paper |
Times cited : (17)
|
References (10)
|